Barriers impeding serologic screening for celiac disease in clinically high-prevalence populations

BACKGROUND: Celiac disease is present in ~1% of the general population in the United States and Europe. Despite the availability of inexpensive serologic screening tests, ~85% of individuals with celiac disease remain undiagnosed and there is an average delay in diagnosis of symptomatic individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbero, Erika M, McNally, Shawna L, Donohue, Michael C, Kagnoff, Martin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016507/
https://www.ncbi.nlm.nih.gov/pubmed/24592899
http://dx.doi.org/10.1186/1471-230X-14-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016507/
https://www.ncbi.nlm.nih.gov/pubmed/24592899
http://dx.doi.org/10.1186/1471-230X-14-42

Ejemplares similares